Mn2+-doped ZrO2@PDA nanocomposite for multimodal imaging-guided chemo-photothermal combination therapy

Ning Chen,Wenhui Fu,Jie Zhou,Linqiang Mei,Jimin Yang,Yang Tian,Qiang Wang,Wenyan Yin

DOI: https://doi.org/10.1016/j.cclet.2021.02.030

IF: 9.1

2021-08-01

Chinese Chemical Letters

Abstract:<p>Developing low toxicity and multifunctional theranostic nanoplatform is the key for precise cancer diagnosis and treatment. Herein, an inorganic-organic hybrid nanocomposite is designed by modifying zirconium dioxide (ZrO₂) with polydopamine (PDA) followed by doping Mn²⁺ ions and functionalizing with Tween 20 (Tween-ZrO₂@PDA-Mn²⁺) for multimodal imaging and chemo-photothermal combination therapy. The as-prepared nanocomposite exhibits good biocompatibility <em>in vitro</em> and <em>in vivo</em>. Specifically, it can be employed as a multifunctional platform not only for computed tomography (CT) imaging and T₁-weighted magnetic resonance (MR) imaging, but also for efficient chemotherapeutic drug doxorubicin hydrochloride (DOX) loading. Importantly, because of the pronounced photothermal conversion performance and controllable DOX release ability triggered by the near-infrared (NIR) irradiation and acidic pH, the synergistic effect between photothermal therapy and chemotherapy results in an enhanced cancer treatment efficacy <em>in vivo</em>. Our work provides a high-performance inorganic-organic hybrid nanotheranostic platform for chemo-photothermal cancer therapy guided by CT and MR imaging.</p>

chemistry, multidisciplinary

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a low - toxicity and multi - functional theranostic nanoplatform for precise cancer diagnosis and treatment. Specifically, the researchers designed an inorganic - organic hybrid nanocomposite. By modifying zirconium dioxide (ZrO₂) and doping Mn²⁺ ions, and then functionalizing Tween 20, a ZrO₂@PDA - Mn²⁺ nanocomposite was formed for multimodal imaging and chemo - photothermal combined therapy.

### Main Objectives:
1. **Improve the efficacy of cancer treatment**: By combining chemotherapy and photothermal therapy, and using near - infrared (NIR) laser irradiation and acid - pH - triggered drug release to achieve a synergistic effect and enhance the efficacy of cancer treatment.
2. **Multimodal imaging**: This nanocomposite can serve as a contrast agent for CT imaging and T1 - weighted MRI imaging, providing precise imaging guidance.
3. **Improve biocompatibility and safety**: By using a polydopamine (PDA) coating and Tween 20 functionalization, ensure that the nanocomposite has good biocompatibility and stability and reduces toxicity to normal tissues.

### Problems Solved:
- **Limitations of chemotherapy**: Although traditional chemotherapy is widely used, its severe side effects limit its application. By combining photothermal therapy, the amount of chemotherapy drugs can be reduced and side effects can be decreased.
- **Limitations of photothermal therapy**: Due to the limited heat energy distribution and the attenuation of laser intensity with depth, stand - alone photothermal therapy may not achieve satisfactory treatment results. Combining chemotherapy can make up for this deficiency.
- **Safety of nanomaterials**: Many inorganic nanomaterials have poor long - term safety without proper surface modification and may have adverse effects on organisms. By using PDA coating and Tween 20 functionalization, the safety of the nanocomposite is improved.

### Experimental Results:
- **In vitro experiments**: The nanocomposite showed good biocompatibility and low cytotoxicity in vitro, as well as efficient photothermal conversion performance and controllable drug - release ability.
- **In vivo experiments**: In a mouse model, the nanocomposite was able to effectively inhibit tumor growth and had no obvious negative impact on the body weight and major organs of the mice. CT and MRI imaging results showed that this nanocomposite can serve as an effective imaging contrast agent.

In conclusion, this study has developed a high - performance inorganic - organic hybrid nanotheranostic platform, providing new ideas for the precise diagnosis and treatment of cancer.